HS/CN kodas 30021010 EUDR parengimui yra nepatenka į taikymo sritį.
Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001) Indeksuotas taikymo srities variklis šiam kodui grąžina Out of scope. No Annex I scope match was found for this indexed CN code.
Kodėl šis informacinis puslapis pateikia tokį atsakymą.
- Kodo aprašymas
- Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001)
- I priedo pagrindas
- Nėra tiesioginio I priedo įrašo
- Šaltinio pagrindas
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Aukštesnio, žemesnio lygio ir gretimos eilutės.
Žinyno rodinys skirtas informacinei navigacijai. Norėdami patikrinti kitą kodą kaip veiksmą, naudokite tikrintuvą.
30skirsnis - farmacijos produktaiout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Ką tai reiškia parengimui.
Ši eilutė dabartiniame taikymo srities rezultate tiesiogiai nesukelia įrodymų rinkimo.
Regulation (EU) 2023/1115 Annex I — relevant productsgauta 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115gauta 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)gauta 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)gauta 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8gauta 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkinggauta 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersgauta 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)gauta 2026-08-08